HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,473,609 | -8.5% | 2,401,562 | +3.0% | 0.00% | – |
| Q2 2023 | $2,704,236 | -29.9% | 2,331,238 | -8.8% | 0.00% | – |
| Q1 2023 | $3,859,978 | -70.2% | 2,555,993 | -50.6% | 0.00% | – |
| Q4 2022 | $12,934,660 | -65.3% | 5,173,864 | -41.5% | 0.00% | -100.0% |
| Q3 2022 | $37,299,000 | -18.1% | 8,838,706 | -45.9% | 0.00% | -33.3% |
| Q2 2022 | $45,557,000 | -38.4% | 16,328,796 | +26.4% | 0.00% | -25.0% |
| Q1 2022 | $73,922,000 | +5.3% | 12,923,369 | +68.0% | 0.00% | +33.3% |
| Q4 2021 | $70,232,000 | +1.2% | 7,692,411 | +18.5% | 0.00% | -25.0% |
| Q3 2021 | $69,398,000 | -5.1% | 6,491,907 | +37.8% | 0.00% | 0.0% |
| Q2 2021 | $73,141,000 | -1.6% | 4,712,719 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $74,311,000 | -11.8% | 4,584,299 | +15.1% | 0.00% | -20.0% |
| Q4 2020 | $84,275,000 | +28.9% | 3,981,804 | -9.7% | 0.01% | +25.0% |
| Q3 2020 | $65,360,000 | +15.7% | 4,410,234 | +14.8% | 0.00% | 0.0% |
| Q2 2020 | $56,493,000 | +40.3% | 3,840,458 | +12.0% | 0.00% | 0.0% |
| Q1 2020 | $40,270,000 | -49.2% | 3,430,125 | +1.6% | 0.00% | -20.0% |
| Q4 2019 | $79,337,000 | +58.1% | 3,376,057 | +24.4% | 0.01% | +25.0% |
| Q3 2019 | $50,190,000 | -33.5% | 2,712,994 | -33.2% | 0.00% | -33.3% |
| Q2 2019 | $75,518,000 | -4.4% | 4,062,313 | +25.7% | 0.01% | 0.0% |
| Q1 2019 | $79,005,000 | -12.6% | 3,232,627 | -7.3% | 0.01% | -25.0% |
| Q4 2018 | $90,427,000 | -12.1% | 3,485,992 | +7.3% | 0.01% | 0.0% |
| Q3 2018 | $102,848,000 | -23.6% | 3,249,484 | -6.3% | 0.01% | -27.3% |
| Q2 2018 | $134,688,000 | +55.2% | 3,466,886 | +10.3% | 0.01% | +57.1% |
| Q1 2018 | $86,761,000 | +115.1% | 3,143,550 | +41.0% | 0.01% | +133.3% |
| Q4 2017 | $40,343,000 | +30.0% | 2,229,023 | +16.0% | 0.00% | 0.0% |
| Q3 2017 | $31,023,000 | +28.9% | 1,920,821 | +10.6% | 0.00% | +50.0% |
| Q2 2017 | $24,063,000 | -10.3% | 1,737,309 | -2.8% | 0.00% | 0.0% |
| Q1 2017 | $26,822,000 | +49.7% | 1,787,678 | +30.7% | 0.00% | 0.0% |
| Q4 2016 | $17,913,000 | -5.3% | 1,367,565 | +24.6% | 0.00% | 0.0% |
| Q3 2016 | $18,915,000 | +5.4% | 1,097,543 | +10.4% | 0.00% | 0.0% |
| Q2 2016 | $17,944,000 | -21.8% | 994,232 | -17.7% | 0.00% | 0.0% |
| Q1 2016 | $22,947,000 | -39.7% | 1,208,572 | -15.1% | 0.00% | -50.0% |
| Q4 2015 | $38,027,000 | +42.0% | 1,424,311 | +29.8% | 0.00% | +33.3% |
| Q3 2015 | $26,776,000 | -28.3% | 1,097,437 | -8.4% | 0.00% | -25.0% |
| Q2 2015 | $37,346,000 | +761.5% | 1,198,577 | +302.5% | 0.00% | – |
| Q1 2015 | $4,335,000 | +87.7% | 297,755 | +29.7% | 0.00% | – |
| Q4 2014 | $2,309,000 | +29.6% | 229,592 | +7.1% | 0.00% | – |
| Q3 2014 | $1,781,000 | -21.9% | 214,365 | +15.8% | 0.00% | – |
| Q2 2014 | $2,281,000 | +1218.5% | 185,162 | +1393.2% | 0.00% | – |
| Q1 2014 | $173,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |